Mn4+-Doped Oxyfluoride Red Phosphors for Narrow-Band LED Conversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional red-emitting luminophores in white light-emitting conversion LEDs suffer from inefficiency due to broad emission bands that result in a significant reduction in photon count in the desired red spectral region, leading to lower color rendering index and luminous efficacy, as the human eye is less sensitive to longer wavelengths.

Innovation Solution

Development of Mn4+-doped oxo fluorides with empirical formulas such as K3MoOF7:Mn4+ and K2NaNbO2F4:Mn4+, which exhibit narrow emission bands and peak wavelengths between 625 nm to 635 nm, optimizing photon emission in the red spectral region for improved color rendering and luminous efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional red-emitting luminophores (Eu2+ or Ce3+) are used, then the emission band is broad, but this leads to severe reduction in efficiency of the conversion LED in relation to eye sensitivity

Engineering Contradiction:
Improveease of manufactureVSAvoidluminous efficacy
Core Design Contradiction:
Ease of manufactureVSLoss of energy

Solution Approach 1:

The patent changes the activator ion from Eu2+ or Ce3+ to Mn4+, which fundamentally alters the emission mechanism from broad band to narrow line emission. This parameter change in the activator ion identity resolves the contradiction by enabling narrow emission lines that match the eye sensitivity curve, thereby improving luminous efficacy while maintaining ease of manufacture through established doping techniques

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent substitutes the emission mechanism from broadband phosphorescence (Eu2+/Ce3+) to line emission (Mn4+). This substitution of the emission mechanism resolves the contradiction by replacing a mechanism that inherently produces broad emission with one that produces narrow emission lines, improving eye sensitivity matching and luminous efficacy

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Loss of energy

If the emission spectrum is shifted to shorter wavelength by variations in chemical composition, then the overlap with eye sensitivity curve increases, but this leads to a reduction in the photon count in the desired red spectral region

Engineering Contradiction:
Improveluminous efficacyVSAvoidphoton count in red spectral region
Core Design Contradiction:
Loss of energyVSQuantity of substance

Solution Approach 1:

The patent changes the activator ion from Eu2+ or Ce3+ to Mn4+, which fundamentally alters the emission mechanism from broad band to narrow line emission. This parameter change resolves the contradiction by enabling precise positioning of emission lines at wavelengths that match eye sensitivity peaks, thereby simultaneously improving luminous efficacy and maintaining high photon count in the red spectral region

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies local quality by concentrating emission intensity at specific wavelengths (620-640 nm) where the eye sensitivity curve has high values, rather than distributing photons across a broad spectrum. This localized emission approach resolves the contradiction by maximizing the overlap with eye sensitivity at critical wavelengths while maintaining total photon output

Inventive Principle:
Principle #3Local quality

3Loss of energy

If Mn4+-doped compounds are used, then the emission spectrum features narrow lines with small FWHM values, but the emission peak is typically at longer wavelengths with lower eye sensitivity

Engineering Contradiction:
Improveluminous efficacyVSAvoideye sensitivity
Core Design Contradiction:
Loss of energyVSIllumination intensity

Solution Approach 1:

The patent changes the host matrix from conventional oxides or fluorides to oxo fluorides with specific empirical formulas (A3M*OxF9-2x or A3MOxF8-2x). This parameter change in the host composition resolves the contradiction by enabling Mn4+ emission lines to be positioned at shorter wavelengths (620-640 nm) that match the eye sensitivity curve, thereby simultaneously achieving narrow emission lines and high eye sensitivity

Inventive Principle:
Principle #35Parameter changes

4Quantity of substance

If high wavelength red radiation is used to achieve deep red emission, then the color rendering index improves, but the luminous efficacy decreases due to lower eye sensitivity

Engineering Contradiction:
Improvecolor rendering indexVSAvoidluminous efficacy
Core Design Contradiction:
Quantity of substanceVSLoss of energy

Solution Approach 1:

The patent changes the activator ion to Mn4+ and the host to oxo fluorides, which positions the emission lines at 620-640 nm. This parameter change resolves the contradiction by finding an optimal balance point where the emission lines are sufficiently red to provide good color rendering (R9 > 90) while remaining at wavelengths where the eye sensitivity curve still has high values, thereby maintaining luminous efficacy

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These luminophores achieve high color rendering index and luminous efficacy by minimizing inefficient photon conversion in the long-wave red region, making them suitable for high-efficiency white LEDs and large color space representation.

Implementation Method 1

the red component of the white overall radiation is produced by the conversion of blue primary light from a semiconductor layer sequence to longer-wave red radiation by means of an inorganic luminophore

Methodology Applied
Scientific EffectPhotoluminescence: Photoluminescence

Data Source

PatentUS12152185B2Manganese-doped red luminescent material and conversion LED
Publication Date: 2024.11.26 OSRAM OPTO SEMICON GMBH & CO OHG
  • US12152185B2 patent drawing
  • US12152185B2 patent drawing
  • US12152185B2 patent drawing

AI summary

A luminophore having the empirical formula A3M*OxF9-2x:Mn4+ where A may be or include Li, Na, Rb, K, Cs, or combinations thereof. M* may be or include Cr, Mo, W, or combinations thereof. x may be or include 0<x<4.5.